16 March 2018 EMA/CVMP/153976/2018 Committee for Medicinal Products for Veterinary Use
MRL summary opinion 1
On 15 March 2018, the Committee for Medicinal Products for Veterinary Use (CVMP) adopted an opinion recommending the amendment of the entry for diflubenzuron in Table 1 (Allowed substances) of the Annex to Commission Regulation (EU) No 37/2010 in accordance with the following table: Pharmaco-
active substance Diflubenzuron
skin in natural
agents / Agents
Summaries of opinion are published without prejudice to the Commission Decision.
30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contact
An agency of the European Union
© European Medicines Agency, 2018. Reproduction is authorised provided the source is acknowledged.